摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-chlorophenyl)(phenyl)(pyridin-2-yl)methanol | 131081-15-7

中文名称
——
中文别名
——
英文名称
(3-chlorophenyl)(phenyl)(pyridin-2-yl)methanol
英文别名
(3-chlorophenyl)(phenyl)(pyridine-2-yl)-methanol;(3-chloro-phenyl)-phenyl-[2]pyridyl-methanol;(3-Chlor-phenyl)-phenyl-[2]pyridyl-methanol;(3-Chlorophenyl)-phenyl-pyridin-2-ylmethanol
(3-chlorophenyl)(phenyl)(pyridin-2-yl)methanol化学式
CAS
131081-15-7
化学式
C18H14ClNO
mdl
——
分子量
295.768
InChiKey
RMXGMRADBOFAGV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    33.1
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (3-chlorophenyl)(phenyl)(pyridin-2-yl)methanol氢碘酸potassium acetate 、 XPhos Pd G3溶剂黄146苯基锂 作用下, 以 四氢呋喃二丁醚N,N-二甲基甲酰胺 为溶剂, 反应 7.25h, 生成 2-[1-phenyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl]pyridine
    参考文献:
    名称:
    封装型伪三(杂配)铱(III)发射体的配体设计和制备、光物理性质和器件性能
    摘要:
    有机分子 2-(1-苯基-1-(吡啶-2-基)乙基)-6-(3-(1-苯基-1-(吡啶-2-基)乙基)苯基)吡啶 ( H 3 L ) 被设计、制备并用于合成封装型伪三(杂配)铱(III)衍生物Ir(κ 6 - fac-C,C',C"-fac-N,N ' ,N" - L)。它的形成是由于杂环与铱中心的配位以及苯基的邻-CH键活化而发生的。二聚体 [Ir(μ-Cl)(η 4 -COD)] 2适合制备 [Ir(9h)] 类化合物(9h = 9-电子供体六齿配体),但 Ir(acac) 3是更合适的起始材料。反应在1-苯基乙醇中进行。与后者相反,2-乙氧基乙醇促进金属羰基化,抑制H 3 L的完全配位。配合物 Ir(κ 6 - fac-C,C',C"-fac-N,N ' ,N"- L) 是一种光激发磷光发射体,已被用来制造四种黄光发射器件,1931 CIE (x :y) ∼ (0.52:0.48) 最大波长为
    DOI:
    10.1021/acs.inorgchem.2c04106
  • 作为产物:
    描述:
    2-苯甲酰吡啶 、 alkaline earth salt of/the/ methylsulfuric acid 在 乙醚 作用下, 生成 (3-chlorophenyl)(phenyl)(pyridin-2-yl)methanol
    参考文献:
    名称:
    Central Stimulants. α,α-Disubstituted 2-Piperidinemethanols and 1,1-Disubstituted Heptahydroöxazolo [3,4-a]pyridines
    摘要:
    DOI:
    10.1021/ja01559a066
点击查看最新优质反应信息

文献信息

  • Organic Electroluminescent Materials and Devices
    申请人:Universal Display Corporation
    公开号:US20200255464A1
    公开(公告)日:2020-08-13
    A compound comprising a hexadentate ligand of Formula I coordinated to a metal selected from the group consisting of iridium, rhodium, and osmium wherein rings A, D, and E are independently a 5-membered or 6-membered heteroaryl ring, or a 6-membered aryl ring; rings B, C, and F are independently 6-membered heteroaryl ring, or a 6-membered aryl ring; T 1 , T 2 , T 3 , T 4 , T 5 , and T 6 are independently selected from C or N, wherein two to four of T 1 to T 6 are C, and two to four of T 1 to T 6 are N; Z 1 , Z 2 , Z 3 , and Z 4 are independently selected from C or N, wherein if Z 1 and Z 2 are each N then T 1 is a carbene carbon and two of T 2 to T 6 are N; J 1 to J 11 are independently selected from C or N, wherein if any one of J 1 to J 4 is N then ring F has no more than three N, if any one of J 5 to J 7 is N then ring B has no more than three N, or if any one of J 8 to J 11 is N then is N then ring C has no more than three N; Y 1 is selected from the group consisting of CR 1 , SiR 1 , B, or N; Y 2 is selected from the group consisting of CR 2 , SiR 2 , B, or N; W 1 is selected from the group consisting of a direct bond, O, S, CR 3 R 4 , SiR 3 R 4 , BR 3 , and NR N1 ; W 2 is selected from the group consisting of a direct bond, O, S, CR 3 R 4 , SiR 3 R 4 , BR 3 , and NR N2 ; W 3 is selected from the group consisting of a direct bond, O, S, CR 3 R 4 , SiR 3 R 4 , BR 3 , and NR N3 ; R N1 , R N2 , and R N3 are independently selected from the group consisting of hydrogen, deuterium, alkyl, aryl, and combinations thereof; wherein R N1 optionally joins with ring A or a J 5 carbon of ring B to form a fused ring R N2 optionally joins with a J 7 carbon of ring B or a J 8 carbon of ring C to form a fused ring, and R N3 optionally joins with ring A or a J 1 carbon of ring J 3 to form a fused ring; R 1 , R 2 , R 3 , and R 4 are independently hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, aryl, heteroaryl, nitrile, sulfanyl, and combinations thereof; wherein any of R 1 , R 2 , R 3 , and R 4 optionally joins with any of Ring A, Ring D, Ring E, or a J 1 -J 11 carbon to form a fused ring; R A to R F independently represent mono to the maximum allowable substitution, or no substitution; each R A to R F is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and any two adjacent substituents R A to R F are optionally joined to form a fused ring.
    化合物包括配体的配方I与从中选择的属配位,其中环A、D和E分别是5-成员或6-成员的杂芳环,或6-成员的芳基环;环B、C和F分别是6-成员的杂芳环,或6-成员的芳基环;T1、T2、T3、T4、T5和T6分别选择自C或N,其中T1到T6中的两到四个是C,T1到T6中的两到四个是N;Z1、Z2、Z3和Z4分别选择自C或N,如果Z1和Z2各为N,则T1是卡宾碳,T2到T6中的两个是N;J1到J11分别选择自C或N,如果J1到J4中的任何一个是N,则环F中的N不超过三个,如果J5到J7中的任何一个是N,则环B中的N不超过三个,或者如果J8到J11中的任何一个是N,则环C中的N不超过三个;Y1选择自CR1、SiR1、B或N;Y2选择自CR2、SiR2、B或N;W1选择自直接键、O、S、CR3R4、SiR3R4、BR3和NRN1的组合;W2选择自直接键、O、S、CR3R4、SiR3R4、BR3和NRN2的组合;W3选择自直接键、O、S、CR3R4、SiR3R4、BR3和NRN3的组合;RN1、RN2和RN3分别选择自氢、、烷基、芳基及其组合;其中RN1可选择与环A或环B的J5碳形成融合环,RN2可选择与环B的J7碳或环C的J8碳形成融合环,RN3可选择与环A或环J3的J1碳形成融合环;R1、R2、R3和R4分别为氢或从、烷基、环烷基、芳基、杂芳基、腈、醚基及其组合中选择的取代基;其中R1、R2、R3和R4中的任何一个可选择与环A、环D、环E或J1-J11碳中的任何一个形成融合环;RA到RF独立表示单个到最大允许的取代基,或无取代;每个RA到RF独立地为氢或从、卤素、烷基、环烷基、杂环烷基、芳基烷基、烷氧基、芳氧基、基、基、烯基、环烯基、杂烯基、炔基、芳基、杂芳基、酰基、羧酸基、醚、酯、腈、异腈、醚基、亚醚基、磺酰基、膦基及其组合中选择的取代基,任何两个相邻的取代基RA到RF可选择结合形成融合环。
  • Organic electroluminescent materials and devices
    申请人:Universal Display Corporation
    公开号:US11370809B2
    公开(公告)日:2022-06-28
    A compound comprising a hexadentate ligand of Formula I coordinated to a metal selected from the group consisting of iridium, rhodium, and osmium wherein rings A, D, and E are independently a 5-membered or 6-membered heteroaryl ring, or a 6-membered aryl ring; rings B, C, and F are independently 6-membered heteroaryl ring, or a 6-membered aryl ring; T1, T2, T3, T4, T5, and T6 are independently selected from C or N, wherein two to four of T1 to T6 are C, and two to four of T1 to T6 are N; Z1, Z2, Z3, and Z4 are independently selected from C or N, wherein if Z1 and Z2 are each N then T1 is a carbene carbon and two of T2 to T6 are N; J1 to J11 are independently selected from C or N, wherein if any one of J1 to J4 is N then ring F has no more than three N, if any one of J5 to J7 is N then ring B has no more than three N, or if any one of J8 to J11 is N then is N then ring C has no more than three N; Y1 is selected from the group consisting of CR1, SiR1, B, or N; Y2 is selected from the group consisting of CR2, SiR2, B, or N; W1 is selected from the group consisting of a direct bond, O, S, CR3R4, SiR3R4, BR3, and NRN1; W2 is selected from the group consisting of a direct bond, O, S, CR3R4, SiR3R4, BR3, and NRN2; W3 is selected from the group consisting of a direct bond, O, S, CR3R4, SiR3R4, BR3, and NRN3; RN1, RN2, and RN3 are independently selected from the group consisting of hydrogen, deuterium, alkyl, aryl, and combinations thereof; wherein RN1 optionally joins with ring A or a J5 carbon of ring B to form a fused ring RN2 optionally joins with a J7 carbon of ring B or a J8 carbon of ring C to form a fused ring, and RN3 optionally joins with ring A or a J1 carbon of ring J3 to form a fused ring; R1, R2, R3, and R4 are independently hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, aryl, heteroaryl, nitrile, sulfanyl, and combinations thereof; wherein any of R1, R2, R3, and R4 optionally joins with any of Ring A, Ring D, Ring E, or a J1-J11 carbon to form a fused ring; RA to RF independently represent mono to the maximum allowable substitution, or no substitution; each RA to RF is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and any two adjacent substituents RA to RF are optionally joined to form a fused ring.
    一种化合物,包含与选自由组成的组中的属配位的式 I 六价配体 其中 环 A、D 和 E 独立为 5 元或 6 元杂芳基环或 6 元芳基环 环 B、C 和 F 独立为 6 元杂芳基环或 6 元芳基环; T1、T2、T3、T4、T5 和 T6 独立选自 C 或 N,其中 T1 至 T6 中的 2 至 4 个为 C,T1 至 T6 中的 2 至 4 个为 N; Z1、Z2、Z3 和 Z4 独立选自 C 或 N,其中如果 Z1 和 Z2 均为 N,则 T1 为碳烯碳,T2 至 T6 中的两个为 N; J1 至 J11 独立选自 C 或 N,其中如果 J1 至 J4 中的任一个为 N,则环 F 具有不超过三个 N,如果 J5 至 J7 中的任一个为 N,则环 B 具有不超过三个 N,或者如果 J8 至 J11 中的任一个为 N,则为 N,则环 C 具有不超过三个 N; Y1 选自 CR1、SiR1、B 或 N 所组成的组; Y2 选自 CR2、SiR2、B 或 N 所组成的组; W1 选自由直接键、O、S、CR3R4、SiR3R4、BR3 和 NRN1 组成的组; W2 选自直接键、O、S、CR3R4、SiR3R4、BR3 和 NRN2 所组成的组; W3 选自由直接键、O、S、CR3R4、SiR3R4、BR3 和 NRN3 组成的组; RN1、RN2 和 RN3 独立选自由氢、、烷基、芳基及其组合组成的组;其中,RN1 可选择与环 A 或环 B 的 J5 碳连接形成融合环,RN2 可选择与环 B 的 J7 碳或环 C 的 J8 碳连接形成融合环,RN3 可选择与环 A 或环 J3 的 J1 碳连接形成融合环; R1、R2、R3 和 R4 独立地为氢或选自由、烷基、环烷基、芳基、杂芳基、腈基、基及其组合组成的组的取代基;其中 R1、R2、R3 和 R4 中的任一个可选择地与环 A、环 D、环 E 中的任一个或 J1-J11 碳连接形成融合环; RA 至 RF 分别代表单取代基至最大允许取代基,或不代表取代基; 每个 RA 至 RF 独立地为氢或选自以下组别的取代基:、卤素、烷基、环烷基、杂烷基、杂环烷基、芳烷基、烷氧基、芳氧基、基、硅烷基、烯基、环烯基、杂烯基、炔基、芳基、炔烃基、炔烃基、炔基、芳基、杂芳基、酰基、羧酸基、醚基、酯基、腈基、异腈基、酰基、亚磺酰基、磺酰基、膦基及其组合,以及 RA 至 RF 的任意两个相邻取代基可选择连接以形成融合环。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫